The Dutch Medicines for Children Research Network (MCRN) was created in 2008 to improve the co-ordination, speed and quality of pediatric trials in the Netherlands.
The Network has extensive knowledge and experience of paediatric research, and supports sponsored initiated studies (CRO or industry-led) as well as academic investigator initiated studies by offering expertise.
The Dutch Medicines for Children Research Network is a category 1 member of Enpr-EMA